S&P's Top Biotech Beneficiaries of Health Care Reform
With the passage of the U.S. Senate's version of the health care reform bill on Christmas Eve, investors may now want to take a look at the growth prospects for the biotech industry. It's likely to benefit from the legislation that's leading to a major health care industry overhaul in 2010.